PROSIEBENSAT1 MED. NPV (PBSFF) Given Neutral Rating at JPMorgan Chase & Co.
PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF)‘s stock had its “neutral” rating reissued by equities research analysts at JPMorgan Chase & Co. in a note issued to investors on Friday.
Separately, DZ Bank AG reissued a “sell” rating on shares of PROSIEBENSAT1 MED. NPV in a report on Friday, August 5th.
PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF) traded up 3.77% during trading on Friday, reaching $42.16. The company had a trading volume of 158 shares. PROSIEBENSAT1 MED. NPV has a 1-year low of $39.66 and a 1-year high of $53.96. The stock has a market capitalization of $9.05 billion and a price-to-earnings ratio of 22.17. The firm has a 50-day moving average of $44.35 and a 200-day moving average of $46.92.
Receive News & Ratings for PROSIEBENSAT1 MED. NPV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROSIEBENSAT1 MED. NPV and related companies with MarketBeat.com's FREE daily email newsletter.